Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain

被引:27
|
作者
Lewis, DA
Jones, A
Parkhill, J
Speert, DP
Govan, JRW
LiPuma, JJ
Lory, S
Webb, AK
Mahenthiralingam, E
机构
[1] Univ Cardiff Wales, Cardiff Sch Biosci, Cardiff CF10 3TL, Wales
[2] Wythenshawe Hosp, Manchester Adult Cyst Fibrosis Ctr, Manchester M23 9LT, Lancs, England
[3] Sanger Inst, Pathogen Sequencing Unit, Cambridge, England
[4] Univ Edinburgh, Sch Med, Dept Med Microbiol, Edinburgh EH8 9AG, Midlothian, Scotland
[5] Univ British Columbia, Dept Pediat, Div Infect & Immunol Dis, Vancouver, BC V5Z 1M9, Canada
[6] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA
[7] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA
关键词
cystic fibrosis; transmission; identification; genomic island;
D O I
10.1165/rcmb.2004-0352OC
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of transmissible Pseudomonas aeruginoso strains have been identified which potentially constitute an emerging threat to patients with cystic fibrosis (CF). We sought to identify DNA markers that were specific to a transmissible P. aeruginosa CIF clone and evaluate these probes on a large collection of genotypically distinct P. aeruginosa strains. Using subtractive DNA hybridization, in combination with analysis using the P. aeruginosa PAO1 genome chip, DNA markers specific for or absent from the Manchester transmissible CIF strain (MA) were identified. Five subtractive DNA hybridization markers (MA15, MA18, MA21, MA22, and MA30) were found to be specific to strain MA and were located within a novel 13,318-bp genomic island, designated the MA island. The MA island encoded 18 genes and consisted of two bacteriophage-like regions, one region encoded the MA-specific subtractive hybridization markers, while the other bacteriophage-like region contained a Vibrio cholera-like toxin gene. Probes MA15, MA18, MA21, MA22, and MA30 were all found to be specific to strain MA when a collection of 141 P. aeruginosa strains was examined by hybridization with each DNA marker. In contrast, a previously isolated DNA marker for the Liverpool transmissible CIF strain, PS21, was not found to be specific, detecting two additional strain types in the collection screened. Both the Manchester and Liverpool strain types were not encountered in CIF populations outside the United Kingdom. The MA genomic island and Vibrio cholera-like toxin gene within it constitute novel genetic factors associated with a transmissible P. aeruginosa strain and their role in pathogenesis remains to be determined.
引用
收藏
页码:56 / 64
页数:9
相关论文
共 50 条
  • [41] IGG AND IGA TITRE AGAINST PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS PATIENTS - MARKERS OF SURVIVAL?
    Moffitt, K. L.
    Wei, L.
    Jones, A.
    Webb, K.
    Martin, S.
    Tunney, M.
    Elborn, J.
    PEDIATRIC PULMONOLOGY, 2011, : 268 - 268
  • [42] Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa
    Ratjen, Felix
    Saiman, Lisa
    Mayer-Hamblett, Nicole
    Lands, Larry C.
    Kloster, Margaret
    Thompson, Valerie
    Emmett, Peggy
    Marshall, Bruce
    Accurso, Frank
    Sogel, Scott
    Anstead, Michael
    CHEST, 2012, 142 (05) : 1259 - 1266
  • [43] A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance
    Salunkhe, P
    Smart, CHM
    Morgan, JAW
    Panagea, S
    Walshaw, MJ
    Hart, CA
    Geffers, R
    Tümmler, B
    Winstanley, C
    JOURNAL OF BACTERIOLOGY, 2005, 187 (14) : 4908 - 4920
  • [44] Effect of Antibiotic Treatment on Bacteriophage Production by a Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa
    Fothergill, Joanne L.
    Mowat, Eilidh
    Walshaw, Martin J.
    Ledson, Martin J.
    James, Chloe E.
    Winstanley, Craig
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (01) : 426 - 428
  • [45] EPIDEMIOLOGY OF PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS AND THE USE OF STRAIN GENOTYPING
    SMITH, DL
    SMITH, EG
    GUMERY, LB
    STABLEFORTH, DE
    DALLACOSTA, LM
    PITT, TL
    JOURNAL OF INFECTION, 1993, 26 (03) : 325 - &
  • [46] Twenty-Five-Year Outbreak of Pseudomonas aeruginosa Infecting Individuals with Cystic Fibrosis: Identification of the Prairie Epidemic Strain
    Parkins, Michael D.
    Glezerson, Bryan A.
    Sibley, Christopher D.
    Sibley, Kristen A.
    Duong, Jessica
    Purighalla, Swathi
    Mody, Christopher H.
    Workentine, Matthew L.
    Storey, Douglas G.
    Surette, Michael G.
    Rabin, Harvey R.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2014, 52 (04) : 1127 - 1135
  • [47] Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis
    Tai, Anna S.
    Sherrard, Laura J.
    Kidd, Timothy J.
    Ramsay, Kay A.
    Buckley, Cameron
    Syrmis, Melanie
    Grimwood, Keith
    Bell, Scott C.
    Whiley, David M.
    BMC PULMONARY MEDICINE, 2017, 17
  • [48] Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis
    Anna S. Tai
    Laura J. Sherrard
    Timothy J. Kidd
    Kay A. Ramsay
    Cameron Buckley
    Melanie Syrmis
    Keith Grimwood
    Scott C. Bell
    David M. Whiley
    BMC Pulmonary Medicine, 17
  • [49] Development of a diagnostic test for the Midlands 1 cystic fibrosis epidemic strain of Pseudomonas aeruginosa
    Smart, Catherine H. M.
    Scott, Fiona W.
    Wright, Elli A.
    Walshaw, Martin J.
    Hart, C. Anthony
    Pitt, Tyrone L.
    Winstanley, Craig
    JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (08) : 1085 - 1091
  • [50] Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat
    Mohan, K.
    Fothergill, J. L.
    Storrar, J.
    Ledson, M. J.
    Winstanley, C.
    Walshaw, M. J.
    THORAX, 2008, 63 (09) : 839 - 840